DGI:ZNS-Infektionen/Anmerkung der Redaktion: Difference between revisions

From Infektiopedia
imported>Brinkery
No edit summary
imported>Maximilian.schons@uk-koeln.de
m (Maximilian.schons@uk-koeln.de verschob die Seite DGI:ZNS Infektionen/Anmerkung der Redaktion nach DGI:ZNS-Infektionen/Anmerkung der Redaktion: Textersetzung - „ZNS Infektionen“ durch „ZNS-Infektionen“)
 
(9 intermediate revisions by one other user not shown)
Line 1: Line 1:
'''Anmerkung der Redaktion'''
== <big>Anmerkung der Redaktion</big> ==
 
 
<span style="box-sizing: inherit;">1. <span style="box-sizing: inherit; font: 7pt &quot;Times New Roman&quot;;">     </span></span> Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K, EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 2;302(21):2323-9
 
<span style="box-sizing: inherit;">2. <span style="box-sizing: inherit; font: 7pt &quot;Times New Roman&quot;;">     </span></span> Kumta N, Roberts JA, Lipman J et al. Antibiotic distribution into cerebrospinal fluid: Can dosing safely account for drug and disease factors in the treatment of ventriculostomy-associated infections? Clin Pharmacokinet 2018; 57: 439–454
 
<span style="box-sizing: inherit;">3. <span style="box-sizing: inherit; font: 7pt &quot;Times New Roman&quot;;">     </span></span> Bassmann U, Roehr AC, Frey OR, Vetter-Kerkhoff C, Thon N, Hope W, Briegel J, Huge V. Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study. Crit Care 2016; 20: 343
 
<span style="box-sizing: inherit;">4. <span style="box-sizing: inherit; font: 7pt &quot;Times New Roman&quot;;">     </span></span> Conen A, Fux CA, Vajkoczy P, Trampuz A. Management of infections associated with neurosurgical implanted devices. Expert Rev Anti Infect Ther 2017;15(3): 241-255
 
<span style="box-sizing: inherit;"><span style="box-sizing: inherit;">5. <span style="box-sizing: inherit; font: 7pt &quot;Times New Roman&quot;;">     </span></span></span>Nau R et al. S1-Leitlinie Hirnabszess. 2016. In: Deutsche Gesellschaft für Neurologie, Hrsg. Leitlinien für Diagnostik und Therapie in der Neurologie. Online: [http://www.dgn.org/leitlinien www.dgn.org/leitlinien]
 
<span style="box-sizing: inherit;">6. <span style="box-sizing: inherit; font: 7pt &quot;Times New Roman&quot;;">     </span></span> Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Scheld WM, van de Beek D, Bleck TB, Garton HJL, Zunt JR. 2017 Infectious Diseases Society of America’s Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clin Infect Dis 2017; 64: e34–e65
 
<span style="box-sizing: inherit;"><span style="box-sizing: inherit;">7. <span style="box-sizing: inherit; font: 7pt &quot;Times New Roman&quot;;">     </span></span></span>Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen - Update 2018. <nowiki>https://www.awmf.org/leitlinien/detail/ll/082-006.html</nowiki>
 
 
1. <span style="box-sizing: inherit;">       </span> Schaberg, T., et al., ''[Tuberculosis Guideline for Adults - Guideline for Diagnosis and Treatment of Tuberculosis including LTBI Testing and Treatment of the German Central Committee (DZK) and the German Respiratory Society (DGP)].'' Pneumologie, 2017. '''71'''(6): p. 325-397.
 
2. <span style="box-sizing: inherit;">       </span> Wilkinson, R.J., et al., ''Tuberculous meningitis.'' Nat Rev Neurol, 2017. '''13'''(10): p. 581-598.
 
3. <span style="box-sizing: inherit;">       </span> Ducomble, T., et al., ''The burden of extrapulmonary and meningitis tuberculosis: an investigation of national surveillance data, Germany, 2002 to 2009.'' Euro Surveill, 2013. '''18'''(12).
 
4. <span style="box-sizing: inherit;">       </span> in ''Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for Its Prevention and Control''. 2011: London.
 
5. <span style="box-sizing: inherit;">       </span> Thwaites, G., et al., ''British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children.'' J Infect, 2009. '''59'''(3): p. 167-87.
 
6. <span style="box-sizing: inherit;">       </span> Marais, S., et al., ''Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome.'' Clin Infect Dis, 2013. '''56'''(3): p. 450-60.
 
7. <span style="box-sizing: inherit;">       </span> Chin, J.H., ''Tuberculous meningitis: Diagnostic and therapeutic challenges.'' Neurol Clin Pract, 2014. '''4'''(3): p. 199-205.
 
8. <span style="box-sizing: inherit;">       </span> Marais, S., et al., ''Tuberculous meningitis: a uniform case definition for use in clinical research.'' Lancet Infect Dis, 2010. '''10'''(11): p. 803-12.
 
9. <span style="box-sizing: inherit;">       </span> Amagon, K.I., O. Awodele, and A.J. Akindele, ''Methionine and vitamin B-complex ameliorate antitubercular drugs-induced toxicity in exposed patients.'' Pharmacol Res Perspect, 2017. '''5'''(5).
 
10. <span style="box-sizing: inherit;">     </span> Prasad, K. and M.B. Singh, ''Corticosteroids for managing tuberculous meningitis.'' Cochrane Database Syst Rev, 2008(1): p. CD002244.
 
11. <span style="box-sizing: inherit;">     </span> Thwaites, G.E., et al., ''Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults.'' N Engl J Med, 2004. '''351'''(17): p. 1741-51.
 
 
1. <span style="box-sizing: inherit;">       </span> Darlow, C.A., et al., ''Microbial aetiology of brain abscess in a UK cohort: Prominent role of Streptococcus intermedius.'' J Infect, 2020. '''80'''(6): p. 623-629.
 
2. <span style="box-sizing: inherit;">       </span> R, N., ''S1-Leitlinie Hirnabszess. .'' In: Deutsche Gesellschaft für Neurologie, Hrsg. Leitlinien für Diagnostik und Therapie in der Neurologie. , 2016.
 
3. <span style="box-sizing: inherit;">       </span> Alvis Miranda, H., et al., ''Brain abscess: Current management.'' J Neurosci Rural Pract, 2013. '''4'''(Suppl 1): p. S67-81.
 
4. <span style="box-sizing: inherit;">       </span> Brouwer, M.C., et al., ''Brain abscess.'' N Engl J Med, 2014. '''371'''(5): p. 447-56.
 
5. <span style="box-sizing: inherit;">       </span> Mishra, A.M., et al., ''Comparison of the magnetization transfer ratio and fluid-attenuated inversion recovery imaging signal intensity in differentiation of various cystic intracranial mass lesions and its correlation with biological parameters.'' J Magn Reson Imaging, 2006. '''24'''(1): p. 52-6.
 
6. <span style="box-sizing: inherit;">       </span> Xu, X.X., et al., ''Can diffusion-weighted imaging be used to differentiate brain abscess from other ring-enhancing brain lesions? A meta-analysis.'' Clin Radiol, 2014. '''69'''(9): p. 909-15.
 
7. <span style="box-sizing: inherit;">       </span> Mishra, A.K., et al., ''Molecular revolution in the diagnosis of microbial brain abscesses.'' Eur J Clin Microbiol Infect Dis, 2014. '''33'''(12): p. 2083-93.
 
8. <span style="box-sizing: inherit;">       </span> Sonneville, R., et al., ''An update on bacterial brain abscess in immunocompetent patients.'' Clin Microbiol Infect, 2017. '''23'''(9): p. 614-620.
 
9. <span style="box-sizing: inherit;">       </span> Sharma, R., K. Mohandas, and R.P. Cooke, ''Intracranial abscesses: changes in epidemiology and management over five decades in Merseyside.'' Infection, 2009. '''37'''(1): p. 39-43.
 
<br />
<br />

Latest revision as of 07:43, 3 August 2021

Anmerkung der Redaktion


Retrieved from "https://wiki.cakele.iodatalabs.dev/index.php?title=DGI:ZNS-Infektionen/Anmerkung_der_Redaktion&oldid=982"